Page last updated: 2024-11-11

bavachalcone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bavachalcone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6450879
CHEMBL ID464428
CHEBI ID187324
SCHEMBL ID1576619
MeSH IDM0495403

Synonyms (20)

Synonym
bavachalcone
(e)-1-[2,4-dihydroxy-5-(3-methyl-but-2-enyl)-phenyl]-3-(4-hydroxy-phenyl)-propenone
(e)-1-[2,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
28448-85-3
LMPK12120045
broussochalcone b
CHEMBL464428
CHEBI:187324
(e)-1-(2,4-dihydroxy-5-(3-methyl-but-2-enyl)-phenyl)-3-(4-hydroxy-phenyl)-propenone
AKOS015896745
CS-3750
BLZGPHNVMRXDCB-UXBLZVDNSA-N
SCHEMBL1576619
AC-34041
HY-N0231
bdbm50486906
mfcd18427734
(2e)-1-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
MS-24835
DTXSID401317977

Research Excerpts

Overview

Bavachalcone is a natural ingredient extracted from Psoralea corylifolia and has various pharmacological effects.

ExcerptReferenceRelevance
"Bavachalcone is a natural ingredient extracted from Psoralea corylifolia and has various pharmacological effects."( Upregulation of A20 and TAX1BP1 contributes to the anti-neuroinflammatory and antidepressant effects of bavachalcone.
Chen, X; Gong, J; Guo, Y; Li, L; Li, Z; Liu, F; Wu, X; Zhang, X; Zhang, Z, 2023
)
1.85

Pharmacokinetics

ExcerptReferenceRelevance
" The developed method was applied to evaluating the pharmacokinetic study of 13 bioactive compounds after oral administration of Psoraleae Fructus in rat of different genders."( Simultaneous characterization of multiple Psoraleae Fructus bioactive compounds in rat plasma by ultra-high-performance liquid chromatography coupled with triple quadrupole mass spectrometry for application in sex-related differences in pharmacokinetics.
Cheng, LY; Song, L; Wu, YL; Yang, L; Yu, YL; Zhang, Y; Zhou, K; Zhou, ZX, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
chalconesA ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1197163Antitumor activity against human K562 cells incubated for 48 hrs by MTT assay2015European journal of medicinal chemistry, Mar-06, Volume: 92Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
AID357965Inhibition of aromatase from human placental microsomes2001Journal of natural products, Oct, Volume: 64, Issue:10
Aromatase inhibitors from Broussonetia papyrifera.
AID1225511Cytotoxicity against human A549 cells after 48 hrs by MTT assay2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Bioactive Metabolites from the Fruits of Psoralea corylifolia.
AID1248069Inhibition of baker's yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate after 30 mins by spectrophotometric analysis2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.
AID1197164Toxicity against HUVEC incubated for 48 hrs by MTT assay2015European journal of medicinal chemistry, Mar-06, Volume: 92Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
AID1225513Increase in SIRT1 (unknown origin) deacetylation activity at 10 uM2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Bioactive Metabolites from the Fruits of Psoralea corylifolia.
AID1666597Induction of DNA damage in human SU8686 cells assessed as increase in gammaH2AX phosphorylation at ser193 at cytotoxic IC50 in presence of 0.3 uM doxorubicin by fluorometry method2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Targeting the DNA damage response (DDR) by natural compounds.
AID1197166Induction of apoptosis in human K562 cells assessed as apoptotic rate at 30 uM after 48 hrs by Annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 5%)2015European journal of medicinal chemistry, Mar-06, Volume: 92Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
AID1225512Cytotoxicity against human K562 cells after 48 hrs by MTT assay2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Bioactive Metabolites from the Fruits of Psoralea corylifolia.
AID1197165Induction of apoptosis in human K562 cells assessed as cell shrinkage/blebbing at 30 uM after 48 hrs2015European journal of medicinal chemistry, Mar-06, Volume: 92Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
AID1666593Induction of DNA damage in human SU8686 cells assessed as increase in gammaH2AX phosphorylation at ser193 at cytotoxic IC50 incubated for 24 hrs by fluorometry method2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Targeting the DNA damage response (DDR) by natural compounds.
AID1693052Inhibition of porcine pancreatic lipase type 22021Bioorganic & medicinal chemistry, 01-01, Volume: 29Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors.
AID1197888Non-competitive inhibition of alpha-glucosidase (unknown origin)2015European journal of medicinal chemistry, Mar-06, Volume: 92Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (20.00)29.6817
2010's7 (46.67)24.3611
2020's5 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.54 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]